The first main classification, molecularly defined medulloblastomas, are divided into four subtypes based on respective markers: WNT-activated, SHH-activated and TP53-wildtype, SHH-activated and TP53-mutant, and non-WNT/non-SHH. Here, SHH is linked to medulloblastoma.